Post by
Infinity on Apr 14, 2024 3:32pm
Evaluable Patients
I was just looking some previous MD & A on the progress of evaluable patients. That seems to me a major concern. on the 30th March, 2023 MD & A we had 53 evaluable patients.
Check this link for their MD & A just over a year ago
https://theralase.com/wp-content/uploads/2023/08/MDA-Q123.pdf
After a full year, we have an evaluable patients at 63. At the same rate we are going to need 4 more years to reach 100 evaluable patients. RDW is talking about completing the clinical study by 2024 and possible commercialization by end 2026. I am hoping taking on Dr. Jewet as a consultant would allow TLT to step on the Gas a bit. I am hoping the during the next month AUA meeting and Advisory board meeting with all TLT principal investigators in the USA would get us some Tail wind and get it going in the right direction.
Just some wishfull thinking on a Lazy Sunday Afternoon.
Comment by
Alamir1111 on Apr 14, 2024 5:07pm
High efficiency easy 1..2 treatment no major side effects supposed to be the cheapest treatment 10 cancer centres.smartest scientists .is there something else we are not aware of?
Comment by
Legit62 on Apr 14, 2024 7:03pm
I think this all boils down to funds,no money, hard to market these sites, hard to market our treatment, a .12 cent stock price on a canadian exchange, we need to push and shove to get this done, it just takes 1 big pharma to realize the money to be made off this technology and we will all be rich, hope im not dreaming after waiting all this time
Comment by
Dumbeldorfwhite on Apr 14, 2024 7:15pm
Been saying this for 2+ years yet the good ole boys club didn't want to listen. I was the one who called more pps due to the slow enrollment yet everyone kept saying the "trial is paid for" ROFL ... these guys